|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007600,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0025646,
umls-concept:C0031715,
umls-concept:C0032854,
umls-concept:C0149925,
umls-concept:C0596988,
umls-concept:C0681842,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1417123,
umls-concept:C1533157,
umls-concept:C1561558
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-9-7
|
|
pubmed:abstractText |
Small cell lung carcinoma (SCLC) has poor prognosis and remains orphan from targeted therapy. MET is activated in several tumour types and may be a promising therapeutic target.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
pubmed-author:AlbanellJJ,
pubmed-author:ArriolaEE,
pubmed-author:ArtoMM,
pubmed-author:Arumí-UríaMM,
pubmed-author:BellosilloBB,
pubmed-author:CañadasII,
pubmed-author:DómineMM,
pubmed-author:GrandiAA,
pubmed-author:HirschF RFR,
pubmed-author:Lopez-VilariñoJ AJA,
pubmed-author:MenéndezSS,
pubmed-author:RojoFF,
pubmed-author:RoviraAA,
pubmed-author:SalidoMM,
pubmed-author:SerranoSS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
814-23
|
|
pubmed:meshHeading |
pubmed-meshheading:21847116-Adult,
pubmed-meshheading:21847116-Aged,
pubmed-meshheading:21847116-Aged, 80 and over,
pubmed-meshheading:21847116-Carcinoma, Small Cell,
pubmed-meshheading:21847116-Cell Line, Tumor,
pubmed-meshheading:21847116-Cell Proliferation,
pubmed-meshheading:21847116-Female,
pubmed-meshheading:21847116-Hepatocyte Growth Factor,
pubmed-meshheading:21847116-Humans,
pubmed-meshheading:21847116-Indoles,
pubmed-meshheading:21847116-Lung Neoplasms,
pubmed-meshheading:21847116-Male,
pubmed-meshheading:21847116-Middle Aged,
pubmed-meshheading:21847116-Mutation,
pubmed-meshheading:21847116-Neoplasm Invasiveness,
pubmed-meshheading:21847116-Phosphorylation,
pubmed-meshheading:21847116-Proto-Oncogene Proteins c-met,
pubmed-meshheading:21847116-Signal Transduction,
pubmed-meshheading:21847116-Sulfones,
pubmed-meshheading:21847116-Survival Analysis
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines.
|
|
pubmed:affiliation |
Oncology Department, Hospital del Mar-Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. earriola@hospitaldelmar.cat
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
